A Phase II Study of Reduced Intensity Allogeneic Bone Marrow Transplant for the Treatment of Myelodysplastic Syndromes.

Trial Profile

A Phase II Study of Reduced Intensity Allogeneic Bone Marrow Transplant for the Treatment of Myelodysplastic Syndromes.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Jan 2015

At a glance

  • Drugs Pentostatin (Primary) ; Ciclosporin; Methotrexate; Methoxsalen; Mycophenolate mofetil
  • Indications Chronic myelomonocytic leukaemia; Graft-versus-host disease; Myelodysplastic syndromes
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Sep 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
    • 19 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top